NASDAQ | ETF
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 6.37% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 6.12% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 5.97% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 5.86% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 3.61% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 3.35% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.43% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 1.59% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 1.5% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 1.28% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.13% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.13% |
| SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 1.12% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 1.04% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 0.99% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 0.99% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 0.95% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 0.95% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 0.92% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 0.92% |
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.